Clinical Trial Update: Treating Hyperexcitability in AD With Levetiracetam [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating levetiracetam for treating hyperexcitability in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Alzheimer Dementia, Alzheimer Disease | Phase 2 | Status: COMPLETED